Replies to post #2333 on Insmed Inc (INSM)

[rstor1]

And, even though Chip denied this on the conference call, one of the big banks (I want to say Lehman) stated in a report that Tercica provided one month of treatment free of charge.

In the January CC there was an intimation of this. I came away with that impression, but I can't quote chapter and verse and am unwilling to listen again (even if it were available.) Bottom-line, I think something like a one-month "sample" is part of their marketing plan.

BTW, I don't think the Endo conference is going to do much in a permanent way for the sp. It's all in the sales numbers at this point. We went up today not in spite of Tercica, but becasue TRCA si showing some traction, so the street is thinking that there may be a market here after all.

Regards,
Bob

[drbio45]

So, they followed patients for 7 days after start of treatment. Now is that start at the low dosages, or start at the higher, effective dose? Remember that all patients are titrated into full dose treatment over a period of time

as usual you hit the nail on the head. Increlex patients were titrated up, starting with a 40 microgram dose.

I am sure they are referring to the hypoglycemia prior to intial dosing and then 7 days after the low dose.

Believe me if Tercica was finding low hypoglycemia in the higher doses it would have mentioned in the press release

THIS WAS A VERY DISiNGENUOUS PRESS RELEASE. It is no different than the quality of their other press releases or trials

They are truly desperate